title: A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients.
authors.affiliation: Department of Surgery, Washington University School of Medicine, St Louis, MO 63110.
authors.forename: D W
authors.initials: DW
authors.lastname: Hanto
authors.forename: M D
authors.initials: MD
authors.lastname: Jendrisak
authors.forename: C S
authors.initials: CS
authors.lastname: McCullough
authors.forename: S K
authors.initials: SK
authors.lastname: So
authors.forename: J W
authors.initials: JW
authors.lastname: Marsh
authors.forename: T
authors.initials: T
authors.lastname: Rush
authors.forename: S
authors.initials: S
authors.lastname: Michalski
authors.forename: D
authors.initials: D
authors.lastname: Phelan
authors.forename: T
authors.initials: T
authors.lastname: Mohanakumar
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002102:Cadaver; D003141:Communicable Diseases / Q000150:complications; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000379:methods*; D016853:Muromonab-CD3; D011446:Prospective Studies; D016019:Survival Analysis
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016853:Muromonab-CD3